We are live on ! Find out more
EVH icon

Evolent Health

207 hedge funds and large institutions have $2.34B invested in Evolent Health in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 71 increasing their positions, 63 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

307% more call options, than puts

Call options by funds: $15.2M | Put options by funds: $3.74M

13% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 63

3% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 39

1% less funds holding

Funds holding: 209207 (-2)

3.39% less ownership

Funds ownership: 98.12%94.74% (-3.4%)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

11% less capital invested

Capital invested by funds: $2.64B → $2.34B (-$301M)

Holders
207
Holders Change
-2
Holders Change %
-0.96%
% of All Funds
3.19%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.12%
New
40
Increased
71
Reduced
63
Closed
39
Calls
$15.2M
Puts
$3.74M
Net Calls
+$11.5M
Net Calls Change
-$36.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$15.8M +$732K +25,530 +5%
SAM
27
Sectoral Asset Management
Quebec, Canada
$15.3M -$13.9M -484,637 -47%
PWAM
28
Park West Asset Management
California
$15.2M -$7.89M -275,000 -33%
KCM
29
Kornitzer Capital Management
Kansas
$14.8M +$15.4M +536,085 New
GC
30
Guggenheim Capital
Illinois
$13.8M +$31.4K +1,096 +0.2%
Bank of America
31
Bank of America
North Carolina
$13.7M +$619K +21,561 +5%
PCM
32
Peregrine Capital Management
Minnesota
$13.6M +$1.5M +52,418 +12%
1M
33
13D Management
New York
$13.3M -$954K -33,272 -6%
GF
34
Gabelli Funds
New York
$12.8M +$430K +15,000 +3%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$11.8M -$51.6K -1,800 -0.4%
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$11.8M +$146K +5,080 +1%
SCA
37
Summit Creek Advisors
Minnesota
$11.7M +$5.64M +196,656 +87%
RPA
38
Rock Point Advisors
Vermont
$10.8M -$746K -26,011 -6%
Principal Financial Group
39
Principal Financial Group
Iowa
$10.5M +$5.57M +194,279 +105%
KCM
40
Kennedy Capital Management
Missouri
$10.4M -$1.07M -37,279 -9%
VCM
41
Voce Capital Management
California
$9.53M
FG
42
Formula Growth
Quebec, Canada
$9.16M -$4.56M -159,125 -32%
SBH
43
Segall Bryant & Hamill
Illinois
$8.87M +$387K +13,483 +4%
Millennium Management
44
Millennium Management
New York
$8.79M +$5.94K +207 +0.1%
Federated Hermes
45
Federated Hermes
Pennsylvania
$8.73M -$4.03M -140,368 -31%
CCM
46
Courage Capital Management
Tennessee
$8.17M -$139K -4,842 -2%
Citadel Advisors
47
Citadel Advisors
Florida
$7.81M +$6.6M +230,135 +442%
Macquarie Group
48
Macquarie Group
Australia
$7.53M +$5.2M +181,433 +200%
Wells Fargo
49
Wells Fargo
California
$7.29M -$1.09M -38,036 -13%
Marshall Wace
50
Marshall Wace
United Kingdom
$6.36M +$5.37M +187,347 +440%

EVH Hedge Fund Activity: Q4 2021 in Review

207 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q4 2021, worth a combined $2.34B — down 11% from $2.64B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new EVH positions and 39 closed out — a net gain of 1 holder — while 71 added to existing stakes and 63 trimmed.

The largest buyer was Fred Alger Management, adding an estimated $61.3M. The largest seller was Fidelity Investments, cutting an estimated $28.5M.

  • 207 institutional investors held Evolent Health (EVH) as of Q4 2021, down from 209 in Q3 2021.
  • Funds reported $2.34B of Evolent Health stock for Q4 2021, down 11% quarter-over-quarter.
  • 40 funds opened new Evolent Health positions in Q4 2021 and 39 closed out, a net change of +1 holder.
  • The largest Evolent Health buyer in Q4 2021 was Fred Alger Management, an estimated $61.3M added.
  • The largest Evolent Health seller in Q4 2021 was Fidelity Investments, an estimated $28.5M sold.

Based on aggregated 13F filings for Q4 2021.